These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17203222)

  • 21. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
    J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
    Lin YJ; Zhen YS
    Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake.
    Pietras K; Stumm M; Hubert M; Buchdunger E; Rubin K; Heldin CH; McSheehy P; Wartmann M; Ostman A
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3779-87. PubMed ID: 14506171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium.
    Sheu LF; Lee WC; Lee HS; Kao WY; Chen A
    J Pathol; 2005 Oct; 207(2):216-23. PubMed ID: 16021677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STI571 (Glivec) affects histamine release and intracellular pH after alkalinisation in HMC-1560, 816.
    Löber K; Alfonso A; Escribano L; Botana LM
    J Cell Biochem; 2008 Feb; 103(3):865-76. PubMed ID: 17615556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.
    Lee AW; Lau KY; Hung WM; Ng WT; Lee MC; Choi CW; Chan CC; Tung R; Cheng PT; Yau TK
    Radiother Oncol; 2008 May; 87(2):204-10. PubMed ID: 18329742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma.
    Alajez NM; Mocanu JD; Shi W; Chia MC; Breitbach CJ; Hui AB; Knowles S; Bell JC; Busson P; Takada K; Lo KW; O'Sullivan B; Gullane P; Liu FF
    Clin Cancer Res; 2008 Aug; 14(15):4891-7. PubMed ID: 18676763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
    Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
    Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
    Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G(2)/m checkpoint accompanied by alterations in Erk and Akt kinase activities.
    Antonsson A; Persson JL
    Anticancer Res; 2009 Aug; 29(8):2893-8. PubMed ID: 19661292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
    Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY
    Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
    Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
    Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular signal-regulated kinase phosphorylation due to menadione-induced arylation mediates growth inhibition of pancreas cancer cells.
    Osada S; Sakashita F; Hosono Y; Nonaka K; Tokuyama Y; Tanaka H; Sasaki Y; Tomita H; Komori S; Matsui S; Takahashi T
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):315-20. PubMed ID: 17922126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of tyrosine kinases PDGFR and C-Kit by imatinib mesylate interferes with postnatal testicular development in the rat.
    Nurmio M; Toppari J; Zaman F; Andersson AM; Paranko J; Söder O; Jahnukainen K
    Int J Androl; 2007 Aug; 30(4):366-76; discussion 376. PubMed ID: 17705809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation.
    Kimura S; Egashira K; Nakano K; Iwata E; Miyagawa M; Tsujimoto H; Hara K; Kawashima Y; Tominaga R; Sunagawa K
    Circulation; 2008 Sep; 118(14 Suppl):S65-70. PubMed ID: 18824771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
    Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
    J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.